Sanguisorba Officinalis L. Suppresses Non-Small Cell Lung Cancer Via Downregulating the PI3K/AKT/mTOR Signaling Pathway Based on Network Pharmacology and Experimental Investigation
Frontiers in pharmacology(2022)
Key words
Sanguisorba officinalis L.,non-small cell lung cancer,network pharmacology,PI3K/AKT/mTOR,ROS
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined